Nationwide Small Cap Index C (GMRCX)

9.13 +0.12  +1.33% Jan 16 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 9.13
Turnover Ratio 17.17%
1 Year Fund Level Flows -132.42M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 3.27% 2.35% 41
3M 11.85% 9.06% 21
6M 9.32% 7.52% 44
YTD 2.13% 0.57% 43
1Y 17.42% 16.76% 52
3Y 7.65% 6.76% 47
5Y 7.95% 8.19% 57
10Y 10.61% 11.00% 71
15Y 7.23% 7.98% 80
20Y 6.28% 8.58% --
As of Jan. 16, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash -0.07% 1.20% 1.26%
Stock 100.1% 100.1% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Nov. 30, 2019

Region Exposure

Americas 99.54%
North America 99.24%
Latin America 0.30%
Greater Europe 0.25%
United Kingdom 0.04%
Europe Developed 0.11%
Europe Emerging 0.02%
Africa/Middle East 0.08%
Greater Asia 0.21%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.13%
Asia Emerging 0.08%
Market Classification
% Developed Markets 99.88%
% Emerging Markets 0.12%
As of Nov. 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 3.55%
Communication Services 2.70%
Consumer Cyclical 9.88%
Consumer Defensive 3.70%
Energy 2.88%
Financial Services 16.50%
Healthcare 17.77%
Industrials 16.84%
Real Estate 9.21%
Technology 13.26%
Utilities 3.71%
As of Nov. 30, 2019

Stock Market Capitalization

Giant 0.00%
Large 0.00%
Medium 17.16%
Small 70.63%
Micro 12.20%
As of Nov. 30, 2019

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 2.63%
Mid Cap Blend 6.58%
Mid Cap Growth 8.64%
Small Cap Value 23.05%
Small Cap Blend 29.33%
Small Cap Growth 29.75%
As of Nov. 30, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
-- E-mini Russell 2000 Index Futures 1.26% -- --
NVCR NovoCure Ltd 0.39% 92.58 -1.91%
ARWR Arrowhead Pharmaceuticals Inc 0.33% 56.20 -1.59%
MDCO The Medicines Co 0.31% -- --
HAE Haemonetics Corp 0.30% 113.81 -1.90%
GNRC Generac Holdings Inc 0.29% 103.53 -0.38%
TDOC Teladoc Health Inc 0.29% 95.65 -1.30%
LITE Lumentum Holdings Inc 0.27% 76.80 -1.22%
FR First Industrial Realty Trust Inc 0.26% 42.88 -0.16%
TECD Tech Data Corp 0.26% 144.26 +0.01%
As of Nov. 30, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks to match the performance of the Russell 2000® Index as closely as possible before the deduction of fund expenses. The fund employs a "passive" management, or indexing, approach, which seeks to match approximately the performance of the Russell 2000® Index before the deduction of fund expenses. It normally invests at least 80% of its net assets in a statistically selected sampling of equity securities of companies included in the Russell 2000® Index. The Russell 2000® Index is composed of approximately 2,000 common stocks of small-cap U.S. companies in a wide range of businesses.
General
Security Type Mutual Fund
Oldest Share Symbol GMRIX
Equity Style Small Cap/Blend
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Blend
Prospectus Objective Small Company
Fund Owner Firm Name Nationwide
Benchmark Index
Russell 2000 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alan Mason 5.76 yrs
Amy Whitelaw 0.59 yrs
Greg Savage 6.92 yrs
Jennifer Hsui 0.59 yrs
Rachel Aguirre 3.59 yrs

Share Classes

Symbol Share Class
GMRAX A
GMRIX Inst
GMSRX Retirement
NWXRX S

Net Fund Flows

1M -3.691M
3M -12.36M
6M -18.85M
YTD -132.42M
1Y -132.42M
3Y -501.52M
5Y -748.45M
10Y -778.18M
As of Dec. 31, 2019

Risk Info

Beta (5Y) 1.154
Historical Sharpe Ratio (10Y) 0.6825
Historical Sortino (All) 0.3874
Daily Value at Risk (VaR) 1% (All) 4.02%
Monthly Value at Risk (VaR) 1% (All) 17.29%

Fundamentals

Dividend Yield TTM (1-16-20) 0.48%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 17.98
Weighted Average Price to Sales Ratio 1.131
Weighted Average Price to Book Ratio 2.005
Weighted Median ROE 5.77%
Weighted Median ROA -0.01%
Forecasted Dividend Yield 1.55%
Forecasted PE Ratio 17.06
Forecasted Price to Sales Ratio 1.059
Forecasted Price to Book Ratio 1.879
Number of Holdings 1982
As of Nov. 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 11.35%
Forecasted Book Value Growth -79.02%
Forecasted Cash Flow Growth 4.81%
Forecasted Earnings Growth 11.03%
Forecasted Revenue Growth 0.86%
As of Nov. 30, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 2000.00 USD
Minimum Subsequent Investment 100.00 USD
Fees
Actual 12B-1 Fee 1.00%
Actual Management Fee 0.19%
Administration Fee 0.10%
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load 1.00%
Maximum Redemption Fee --
Key Dates
Inception Date 10/22/2003
Termination Date
Last Annual Report Date 10/31/2019
Last Prospectus Date 2/28/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.